Shkreli’s KaloBios Files for Bankruptcy

BROKE

Updated Apr. 13, 2017 6:11PM EDT / Published Dec. 30, 2015 6:57AM EST

KaloBios Pharmaceuticals, the California-based drug maker that fired bad-boy CEO Martin Shkreli this month after he was arrested on securities-fraud charges, filed for Chapter 11 bankruptcy protection Tuesday. Shkreli bought 70 percent of KaloBios’s shares in November, two months after he sparked widespread criticism for acquiring the license to the AIDS-related drug Daraprim then raising its price by 5,556 percent, to $750 per tablet through his other company, Turing Pharmaceuticals.

Read it at Reuters

Trump Trial Reveals Other Stars Who Paid to Bury Stories

David Pecker, the former National Enquirer publisher, dished the details during his testimony Thursday.

Dan Rather to Appear on CBS News 18 Years After Messy Exit

Rather, 92, is slated to speak about his time at CBS in an interview set to air Sunday.

Founding Member of The Moody Blues Dead at 82

The English rocker founded the band in 1964 and was inducted into the Rock and Roll Hall of Fame in 2018.

Doug Emhoff Quietly Called Columbia’s Jewish Leaders

The move by Vice President Kamala Harris’ husband comes as the White House is under pressure to respond to pro-Palestinian protests.

Cousin Hopes Josh Duggar Is Experiencing ‘Absolute Torture’

Three years after the former “19 Kids And Counting” star was arrested for child sex abuse materials, his cousin Amy says she still wishes him the worst.

3 Women Got HIV From ‘Vampire Facials’ at Shady Spa

The Albuquerque clinic was unlicensed and unsanitary, officials say.

ByteDance Won’t Sell TikTok to Protect Its Algorithm: Report

Sources said that if the company’s legal challenges fail, ByteDance would be willing to call it a loss.

Why Columbia’s Senate Won’t Censure President Over Protests

The faculty body is set to vote on a watered-down version of a resolution against her.

Shkreli’s KaloBios Files for Bankruptcy

© Lucas Jackson / Reuters